The large unmet need for a treatment for autism spectrum disorder is reflected in its diverse pipeline of drugs being developed.
A large-scale clinical study of 1,700 patients showed ubrogepant to be effective at easing pain and light or sound sensitivity as well as providing nausea relief.
Libella Gene Therapeutics has received approval from an institutional review board (IRB) to conduct a clinical trial in Colombia of a gene therapy intended to treat and reverse ageing.
Evolution Research Group (ERG) and Konica Minolta’s Invicro have collaborated to provide early-to-late-phase clinical research services for biotech and pharma sponsors.
Therapix Biosciences has announced that investigational drug THX-110 yielded favourable data in a Phase IIa clinical trial involving adults with obstructive sleep apnea (OSA).